Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Verhamme

Showing results (261-270 of 321) with videos related to

Pageof 33
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 13, 2021
Normal-tension glaucomatous optic neuropathy is related to blood pressure variability in the Maracaibo Aging StudyJesus D Melgarejo, Gladys E Maestre, Luis J Mena, et al.
Seminars in Thrombosis and Hemostasis|April 24, 2021
Venous Thromboembolism in Patients Discharged after COVID-19 HospitalizationMatthias M Engelen, Christophe Vandenbriele, Tim Balthazar, et al.
The New England Journal of Medicine|June 23, 2015
Idarucizumab for Dabigatran ReversalCharles V Pollack, Paul A Reilly, John Eikelboom, et al.
Plos One|March 13, 2018
Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunctionFang-Fei Wei, Sander Trenson, Pierre Monney, et al.
The New England Journal of Medicine|March 28, 2012
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism, Harry R Büller, Martin H Prins, et al.
Hypertension (Dallas, Tex. : 1979)|November 26, 2014
Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish populationYan-Ping Liu, Yu-Mei Gu, Lutgarde Thijs, et al.
Hypertension (Dallas, Tex. : 1979)|February 23, 2024
Mortality and Cardiovascular End Points In Relation to the Aortic Pulse Wave Components: An Individual-Participant Meta-AnalysisGavin R Norton, De-Wei An, Lucas S Aparicio, et al.
The New England Journal of Medicine|December 13, 2017
Edoxaban for the Treatment of Cancer-Associated Venous ThromboembolismGary E Raskob, Nick van Es, Peter Verhamme, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2021
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxabanFloris T M Bosch, Frits I Mulder, Menno V Huisman, et al.
BMC Medical Genetics|April 29, 2017
PEAR1 is not a major susceptibility gene for cardiovascular disease in a Flemish populationWen-Yi Yang, Thibault Petit, Nicholas Cauwenberghs, et al.
Pageof 33

Showing results (261-270 of 321) with videos related to

Sort By:
Pageof 33
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 13, 2021
Normal-tension glaucomatous optic neuropathy is related to blood pressure variability in the Maracaibo Aging StudyJesus D Melgarejo, Gladys E Maestre, Luis J Mena, et al.
Seminars in Thrombosis and Hemostasis|April 24, 2021
Venous Thromboembolism in Patients Discharged after COVID-19 HospitalizationMatthias M Engelen, Christophe Vandenbriele, Tim Balthazar, et al.
The New England Journal of Medicine|June 23, 2015
Idarucizumab for Dabigatran ReversalCharles V Pollack, Paul A Reilly, John Eikelboom, et al.
Plos One|March 13, 2018
Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunctionFang-Fei Wei, Sander Trenson, Pierre Monney, et al.
The New England Journal of Medicine|March 28, 2012
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism, Harry R Büller, Martin H Prins, et al.
Hypertension (Dallas, Tex. : 1979)|November 26, 2014
Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish populationYan-Ping Liu, Yu-Mei Gu, Lutgarde Thijs, et al.
Hypertension (Dallas, Tex. : 1979)|February 23, 2024
Mortality and Cardiovascular End Points In Relation to the Aortic Pulse Wave Components: An Individual-Participant Meta-AnalysisGavin R Norton, De-Wei An, Lucas S Aparicio, et al.
The New England Journal of Medicine|December 13, 2017
Edoxaban for the Treatment of Cancer-Associated Venous ThromboembolismGary E Raskob, Nick van Es, Peter Verhamme, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2021
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxabanFloris T M Bosch, Frits I Mulder, Menno V Huisman, et al.
BMC Medical Genetics|April 29, 2017
PEAR1 is not a major susceptibility gene for cardiovascular disease in a Flemish populationWen-Yi Yang, Thibault Petit, Nicholas Cauwenberghs, et al.
Pageof 33